OCA: Underlying EBITDA up 4.1% and sales volumes up 9.2%, with strong cashflow and debt reduction focus

About this update from Oceania Healthcare Ltd.

Oceania delivered a 4.1% increase in underlying EBITDA and 9.2% higher sales volumes, supported by operational optimisation and a successful $500m bank refinance. Focus remains on reducing unsold stock, cost savings, and portfolio modernisation. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Oceania Healthcare Ltd.